SUMMER IRELAN: Open Payments
NPI 1508909896 · HIGHLANDS RANCH, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 34 payments from 13 companies in 2025. Trend: 2023 $345 · 2024 $789 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $237 |
| Novo Nordisk Inc | 5 | $102 |
| ABBVIE INC. | 3 | $83 |
| PFIZER INC. | 4 | $80 |
| Lilly USA, LLC | 3 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $61 |
| SANOFI PASTEUR INC. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: AIRSUPRA, QULIPTA, KISUNLA, XIFAXAN, NURTEC ODT, PREVNAR 20, FLUZONE HIGH-DOSE, Ozempic.
Industry payments across CO — which companies pay providers there.
